Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
05Oct2025
  • Home
  • About
  • News
  • Subscribe
05Oct2025
Cost Curve NewsCost Curve News
Cost Curve News

The FDA Assault on DTC Advertising Is Targeting a Lot More Than Just TV Ads

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 weeks ago
Keep Reading
Cost Curve News

Payers Say COVID and Flu Vaccine Reimbursements Will Remain Solid, Regardless of CDC Changes

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 weeks ago
Keep Reading
Cost Curve News

The Second-Day Reaction to the DTC Letters: Oprah Gets a Look, Pharma Gets Targeted, and FDA’s Capacity Gets Questioned

It’s a quick one today.  I’m on the road, attending the Oliver Wyman Health Innovation Summit. I had the opportunity to share the stage yesterday with ICER’s Sarah Emond, and
3 weeks ago
Keep Reading
Cost Curve News

A Smart Tufts CEVR Look at Every Cost-Effectiveness Analysis Published for the Meds CMS Is Currently ‘Negotiating’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 weeks ago
Keep Reading
Cost Curve News

The UK Abandoned Biopharma Innovation. Now Biopharma Is Abandoning the UK

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 weeks ago
Keep Reading
Cost Curve News

Was the White House’s Attack on DTC Advertising Fueled by Robots?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 weeks ago
Keep Reading
Cost Curve News

340B Remains In the Spotlight, With New Legislation, Court Battles, and the Pending Rebate Model Launch

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 weeks ago
Keep Reading
Cost Curve News

I’m Not Sure Where to Begin Today. Health Costs? 340B? DTC Ads? Patent Shenanigans?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 weeks ago
Keep Reading
Cost Curve News

Hospitals Allege 340B Collusion in a Context-Free Letter to the DOJ and FTC

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 weeks ago
Keep Reading
Cost Curve News

The Complexity of COVID Vaccine Regulation Is Hampering Patient Access

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 weeks ago
Keep Reading
123

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

October 1, 2025

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

September 30, 2025

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

September 29, 2025

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,631)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,695)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,606)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,489)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,470)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe